Search results
Results From The WOW.Com Content Network
Navicular syndrome, often called navicular disease, is a syndrome of lameness problems in horses. It most commonly describes an inflammation or degeneration of the navicular bone and its surrounding tissues, usually on the front feet. It can lead to significant and even disabling lameness. [1]
Mueller–Weiss syndrome, also known as Mueller–Weiss disease, is a rare [2] idiopathic degenerative disease of the adult navicular bone characterized by progressive collapse and fragmentation, leading to mid- and hindfoot pain and deformity. [3] [1] It is most commonly seen in females, ages 40–60. [4]
Köhler disease (also spelled "Kohler" and referred to in some texts as Kohler disease I) [1] is a rare bone disorder of the foot found in children between six and nine years of age. The disease typically affects boys, but it can also affect girls. It was first described in 1908 by Alban Köhler (1874–1947), a German radiologist.
Navicular disease or navicular syndrome: a catch-all phrase used to describe pain in the palmar hoof which was originally attributed to damage to the navicular bone. MRI has since shown that navicular syndrome may be caused by damage to any of the structures within the hoof, including the navicular bone, the navicular bursa, the coffin joint ...
The two brothers have Duchenne muscular dystrophy — a rare, inherited muscle-wasting disorder that has no cure. "Caleb stopped walking in December of '23, so a little over a year ago.
The average life expectancy in the U.S. is 77.5 years, according to the Centers for Disease Control and Prevention. But Americans outlive their health spans by 12.4 years, the study found.
It flooded three times in just two years, and it has been stripped down to the studs again. The home is now listed for $425,000, reflecting the cost of flood repairs that still need to be completed.
In veterinary medicine, tiludronic acid is used to treat navicular disease and bone spavin in horses. Its tradenames are Tildren and Equidronate. It is approved for treatment of navicular disease and distal, tarsal osteoarthritis in Europe, [1] and was approved for treatment of navicular disease in the United States in 2014.